In line, here, we showed that siRNAs against: ATG5, ATG7, or Beclin1 introduced to normoxic or hypoxic lung cancer cells prior to CIS treatment, did not changed their ability to induce senescence or senescence escaping. Here, ATG7 is linked to in situ carcinoma.